Abstract
Seventy-seven hemophilic patients of type A or type B were subjected to a total of 108 major surgical procedures mainly in the field of general surgery, orthopedic surgery, or neurosurgery. The principles for the substitution therapy in the different types of procedures and different types of hemophilic diseases are described, as well as the indications for surgery and the surgical technique. The importance of prolonged substitution therapy postoperatively to avoid late hematoma, particularly in patients with severe hemophilia undergoing major surgery, is stressed. With this type of management there has been no increased intraoperative hemorrhage, and very few cases of late hematoma formation. By combining the substitution therapy with immunosuppression, it has been possible to operate also on patients with inhibitors against factor VIII or IX. The rate of complications, particularly the incidence of hepatitis, has been low with the type of substitution given in this series of patients. It is concluded that major surgery can be carried out even in severe hemophilia without significantly increased risk. The handling of the substitution therapy, and the surgical judgment and technique, offers however, special problems, necessitating centralization of elective cases.
Résumé
Soixante-dix-sept (77) patients porteurs d'hémophylie A ou B furent soumis à un total de centhuit (108) opérations chirurgicales majeures relevant principalement de la chirurgie générale, de la chirurgie orthopédique ou de la neurochirurgie. L'article décrit les principes guidant le remplacement des facteurs anti-hémophyliques selon les différents types d'hémophylie et d'intervention ainsi que les indications opératoires et la technique chirurgicale. On y souligne l'importance de prolonger la thérapie de substitution durant la période post-opératoire pour éviter la formation d'hématome tardif, en particulier chez les cas d'hémophylie grave soumis à des interventions chirurgicales majeures. Grâce au traitement employé, on a évité les hemorragies peropératoires et quelques rares cas seulement d'hématomes post-opératoires ont été observés. En combinant le remplacement des facteurs anti-hémophyliques et l'immunosuppression, mÊme les patients porteurs d'inhibiteurs des facteurs VIII et IX ont pu Être opérés. Le taux de complication, en particulier l'incidence d'hépatite, est demeuré bas. En conclusion, l'hémophylie mÊme sévère est compatible avec la chirurgie majeure et ce, sans augmentation significative du risque opératoire. Cependant, l'application du traitement de substitution de mÊme que le jugement et la technique chirurgicale posent des problÊmes importants qui nécessitent la centralisation des cas électifs.
Similar content being viewed by others
References
Craddock, C.G., Jr., Fenninger, L.D., Simmons, B.: Hemophilia. Problem of surgical intervention for accompanying diseases. Review of the literature and report of a case. Ann. Surg.128:888, 1948
Pieper, G.R., Perry, S., Burroughs, J.: Surgical intervention in hemophilia. Review of the literature and report of two cases. JAMA170:33, 1959
Bidwell, E.: The purification of bovine antihaemophilic globulin. Br. J. Haematol.1:35, 1955
Biggs, R., MacFarlane, R.G. (editors): Treatment of Haemophilia and Other Coagulation Disorders. Oxford, Blackwell Scientific Publications, 1966
BlombÄck, B., BlombÄck, M.: Purification of human and bovine fibrinogen. Arkiv. Kemi.10:415, 1956
Nilsson, I.M., BlombÄck, B., BlombÄck, M., Svennerud, S.: Kvinnlig hÄmofili och dess behandling med humant anti-hÄmofiliglobulin. Nord. Med.56:1654, 1956
BlombÄck, M., Nilsson, I.M.: Treatment of hemophilia A with human antihemophilic globulin. Acta. Med. Scand.161:301, 1958
Pool, J.G., Robinson, J.: Observations on plasma banking and transfusion procedures for haemophilic patients using a quantitative assay for antihaemophilic globulin (AHG). Br. J. Haematol.5:24, 1959
Brinkhous, K.M., Shanbrom, E., Roberts, H.R., Webster, W.P., Fekete, L., Wagner, R.H.: A new high-potency glycineprecipitated antihemophilic factor (AHF) concentrate. JAMA205:613, 1968
Soulier, J.P., Blatrix, C., Steinbuch, M.: Fractions “coagulantes” contenant les facteurs de coagulation adsorbables par le phosphate tricalcique. Nouv. Presse Med.72:1223, 1964
Soulier, J.P., Ménaché, D., Steinbuch, M., Blatrix, Ch., Josso, F.: Preparation and clinical use of PPSB (factors II, VII, X and IX concentrate). Thromb. Diath. Haemorrh. Suppl.35:61, 1969
Josso, F., Steinbuch, M., Ménaché, D., Blatrix, C., Soulier, J.P.: Preparation of factor IX concentrates, with special reference to the PPSB fraction. In Hemophilia and New Hemorrhagic States, K.M. Brinkhous, editor. International Symposium, New York. Chapel Hill, University of North Carolina Press, 1970, pp. 14–21
Tullis, J.L., Melin, M., Jurigian, P.: Clinical use of human prothrombin complexes. N. Engl. J. Med.273:667, 1965
Britten, A.F.H., Salzman, E.W.: Surgery in congenital disorders of blood coagulation. Surg. Gynecol. Obstet.123:1333, 1966
Biggs, R.: Major surgery in haemophilic patients. In Treatment of Haemophilia and Other Coagulation Disorders, R. Biggs, R.G. MacFarlane, editors. Oxford, Blackwell Scientific Publications, 1966, pp. 166–194
Tarnay, Th.J.: Surgery in the Hemophiliac. Springfield, Ill., Charles C. Thomas, Publisher, 1968
Rudowski, W.J., Ziemski, J.M.: Extensive surgical procedures in patients with hemophilia A. Surg. Gynecol. Obstet.135:571, 1972
Post, M., Telfer, M.C.: Surgery in hemophilic patients. J. Bone Joint Surg.57A:1136, 1975
Björlin, G., Nilsson, I.M.: Tooth extractions in hemophiliacs after administration of a single dose of factor VIII or factor IX concentrate supplemented with AMCA. Oral Surg.36:482, 1973
Nilsson, I.M., BlombÄck, M., Ramgren, O.: Haemophilia in Sweden. I. Coagulation studies. Acta Med. Scand.170:665, 1961
Ramgren, O., Nilsson, I.M., BlombÄck, M.: Haemophilia in Sweden. IV. Hereditary investigations. Acta Med. Scand.171:759, 1962
Ramgren, O.: A clinical and medico-social study of haemophilia in Sweden. Acta Med. Scand. (Suppl.)379:111, 1962
Nilsson, I.M., Ramgren, O., BlombÄck, M., Ahlberg, å.: Addendum to the review of haemophilia in Sweden in 1962. Acta Orthop. Scand. (Suppl.)77:99, 1965
Niléhn, J.-E., Nilsson, I.M.: Haemophilia B in a girl. Thromb. Diath. Haemorrh.7:552, 1962
Nilsson, I.M., Ahlberg, å., Björlin, G.: Clinical experience with a Swedish factor IX concentrate. Acta Med. Scand.190:257, 1971
Nilsson, I.M., BlombÄck, M., Ahlberg, å.: Our experience in Sweden with prophylaxis on haemophilia. The haemophiliac and his world. Proceedings of the 5th Congress of the World Federation for Hemophilia, Montreal, 1968. Bibl. Haematol.34:111, 1970
Nilsson, I.M.: Haemorrhagic and Thrombotic Diseases. New York, John Wiley & Sons, 1974
Holmberg, L., Nilsson, I.M.: Immunologic studies in haemophilia A. Scand. J. Haematol.10:12, 1973
Nilsson, I.M., Hedner, U., Björlin, G.: Suppression of factor IX antibody in hemophilia B by factor IX and cyclophosphamide. Ann. Intern. Med.78:91, 1973
Nilsson, I.M., BlombÄck, M., Ramgren, O.: Haemophilia in Sweden. VI. Treatment of haemophilia A with the human antihaemophilic factor preparation (fraction I-0). Acta Med. Scand. (Suppl.)379:61, 1962
Abildgaard, C.F., Cornet, J.A., Fort, E., Schulman, I.: Thein vivo longevity of antihaemophilic factor (Factor VIII). Br. J. Haematol.10:225, 1964
Loeliger, E.A., Hensen, A., Mattern, M.J., Veltkamp, J.J., Bruning, P.F., Hemker, H.C.: Treatment of haemophilia B with purified factor IX (PPSB). Folia Med. Neerl.10:112, 1967
Biggs, R., Denson, K.W.E.: The fate of prothrombin and factors VIII, IX and X transfused to patients deficient in these factors. Br. J. Haematol.9:532, 1963
Nilsson, I.M., Hedner, U.: Immunosuppressive treatment in haemophiliacs with inhibitors to factor VIII and factor IX. Scand. J. Haematol. (in press)
Duthie, R.B., Matthews, J.M., Rizza, Ch.R., Steel, W.M., Woods, C.G.: The Management of Musculo-skeletal Problems in the Haemophilias. Oxford, Blackwell Scientific Publications, 1972
Kasper, C.K.: To the editor: Postoperative thromboses in hemophilia B. N. Engl. J. Med.289:160, 1973
Blatt, P.M., Lundblad, R.L., Kingdon, H.S., McLean, G., Roberts, H.R.: Thrombogenic materials in prothrombin complex concentrates. Ann. Intern. Med.81:766, 1974
Kasper, C.K.: Thromboembolic complications. Thromb. Diath. Haemorrh.33:640, 1975
Hedner, U., Nilsson, I.M., Bergentz, S.-E.: Various prothrombin complex concentrates and their effect on coagulation and fibrinolysis in vivo. Thromb. Haemostas.35:386, 1976
Craske, J., Dilling, N., Stern, D.: An outbreak of hepatitis associated with intravenous injection of factor-VIII concentrate. Lancet2:221, 1975
Dane, D.S., Cameron, C.H.: Letter to the editor: Factor-VIII concentrate and hepatitis. Lancet2:328, 1975
Roberts, H.R., Blatt, P.M.: Post-transfusion hepatitis following the use of prothrombin complex concentrates. Thromb. Diath. Haemorrh.33:610, 1975
Björkman, S.E., Nilsson, I.M.: Demonstration of a fibrinolytic activator in red bone marrow. Acta Haematol. (Basel)26:273, 1961
MacFarlane, R.G., Biggs, R.: Haemophilia as a social problem. In Treatment of Haemophilia and Other Coagulation Disorders, R. Biggs, R.G. MacFarlane, editors. Oxford, Blackwell Scientific Publications, 1966, p. 328
Author information
Authors and Affiliations
Additional information
International treatment and training centre of the World Federation of Hemophiliacs.
Supported by grants from the Swedish Medical Research Council (B76-19X-00087-12B), (B76-17X-00759-11B).
Rights and permissions
About this article
Cite this article
Nilsson, I.M., Hedner, U., Ahlberg, å. et al. Surgery of hemophiliacs—20 years' experience. World J. Surg. 1, 55–66 (1977). https://doi.org/10.1007/BF01654733
Issue Date:
DOI: https://doi.org/10.1007/BF01654733